1-1 of 1 results for subject:"CP Pharmaceuticals"
Librarians' tools
- Search time
- 0.131 seconds
- Solr query time
- 0.003 seconds
- Search query
- subject:"CP Pharmaceuticals"
- We searched for
- subject_t:"CP Pharmaceuticals" OR subject_t:"C P Pharmaceuticals" OR subject_t:"CP Pharmaceuticals Limited" OR subject_ses:27760
Type
House
Session
Year
Department
Member
Primary member
Answering member
Legislative stage
Legislation
Subject
Publisher
Adjournment debate on diabetes.
Adjournment debate on diabetes.
Lead member
David Amess
Answering member
Stephen Ladyman
Department
Department of Health
Type
Adjournment debates
Subjects
Diabetes; Diagnosis; Food; Labelling; Health education; Medical treatments; Nutrition; Nurses; Staff; Obesity; Side effects; Pfizer; Insulin; CP Pharmaceuticals; Novo Nordisk
Date
16 November 2004
Reference
426 c1327-34
Chamber / Committee
House of Commons chamber
House
House of Commons